Halozyme Therapeutics, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 2,389 | 0.0% | 35,505 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,767 | 0.0% | 37,732 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 1,877 | 0.0% | 36,081 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 2,046 | 0.0% | 32,068 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 1,572 | 0.0% | 32,872 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,753 | 0.0% | 30,631 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 1,521 | 0.0% | 29,045 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 1,070 | 0.0% | 26,305 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 1,012 | 0.0% | 27,371 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 1,026 | 0.0% | 26,867 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 841 | 0.0% | 23,307 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 798 | 0.0% | 20,903 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 1,150 | 0.0% | 20,206 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 735 | 0.0% | 18,581 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 736 | 0.0% | 16,734 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 751 | 0.0% | 18,819 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 778 | 0.0% | 19,344 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 586 | 0.0% | 14,393 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 652 | 0.0% | 14,368 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 594 | 0.0% | 14,245 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 722 | 0.0% | 16,912 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 419 | 0.0% | 15,944 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 427 | 0.0% | 15,944 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 201 | 0.0% | 11,147 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 178 | 0.0% | 10,036 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 593 | 0.0% | 60,000 | 6/30/2014 |
| 2014 Q1 | 4/29/2014 | 508 | 0.0% | 40,000 | 3/31/2014 |
| 2013 Q4 | 2/3/2014 | 600 | 0.0% | 40,000 | 12/31/2013 |